The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Myers Scott Dunseth since year 2005.
The trader's CIK number is 1356256.
At the time of this reporting, Myers Scott Dunseth is the President and CEO of Cascadian Therapeutics, Inc. .
(stock ticker symbol CASC).
See this page for all insider trading activities at Cascadian Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-11||CASC||Cascadian Therapeutics, Inc.||Option Ex||10,500||.00||0|
|2017-08-11||CASC||Cascadian Therapeutics, Inc.||Buy||5,500||3.73||20,542|
|2017-05-12||CASC||Cascadian Therapeutics, Inc.||Buy||2,800||4.00||11,191|
|2017-03-31||CASC||Cascadian Therapeutics, Inc.||Buy||2,000||4.11||8,228|
|2017-03-20||CASC||Cascadian Therapeutics, Inc.||Buy||1,000||3.93||3,927|
|2017-01-27||CASC||Cascadian Therapeutics, Inc.||Buy||20,500||3.76||77,039|
|2016-08-17||CASC||Cascadian Therapeutics, Inc.||Buy||45,000||1.15||51,749|
|2016-06-28||CASC||Cascadian Therapeutics, Inc.||Buy||62,500||.80||50,000|
|2006-05-24||DOVP||Dov Pharmaceutical Inc||Buy||5,000||2.69||13,450|
|2006-05-25||DOVP||Dov Pharmaceutical Inc||Buy||5,000||2.69||13,450|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Myers Scott Dunseth (President and CEO of Cascadian Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.